Fier d'assister au congrès virtuel ISPOR Europe 2020!
PeriPharm est fier d'assister et de présenter certaines collaborations au congrès virtuel ISPOR 2020 qui se tiendra du 16 au 19 novembre.

-
Beauchemin C, Charron JN, Mathurin K, Jobin Gervais K, Barbeau M, Agoumi Y. Cost per Responder Analysis of Latanoprostene Bunod Compared to Prostaglandin Analogs for Open-Angle Glaucoma in Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PSS5), Nov. 2020, Milan, Italy (virtual meeting) link
-
Beauchemin C, Guinan K, Mathurin K, Dufresne SF, Rotstein C, Claveau D, Landry L, Lachaine J. Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis- A Canadian Cost-Utility Analysis. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PIN44), Nov. 2020, Milan, Italy (virtual meeting) link
-
Lachaine J, Charron JN, Gregoire JC, Hegele RA, Leiter LA. Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PCV55), Nov. 2020, Milan, Italy (virtual meeting) link